Jefferies Financial Group Inc. Harmony Biosciences Holdings, Inc. Transaction History
Jefferies Financial Group Inc.
- $13.5 Billion
- Q3 2024
A detailed history of Jefferies Financial Group Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 216,600 shares of HRMY stock, worth $8.23 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
216,600
Previous 50,500
328.91%
Holding current value
$8.23 Million
Previous $1.52 Million
468.15%
% of portfolio
0.06%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
247Shares Held
45.5MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$426 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$222 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$132 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$99.1 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$86.7 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.25B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...